RNTX · Rein Therapeutics, Inc. · Executive Compensation
Market Cap
$64.56M
Shares
86.27M
Volume · Oct 5
220.49K
Avg daily vol (3M)
425.02K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Brian Windsor | President and Chief Executive Officer | $882,695 |
| Timothy M. Cunningham | Interim Chief Financial Officer | $433,940 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Manuel C. Alves Aivado | M.D., Ph.D. Former President and Chief Financial Officer | $1,331,919 |
| Brian Windsor | President and Chief Executive Officer | $778,159 |
| Charles T. Garner | Former principal financial officer and principal accounting officer | $475,961 |
| Timothy M. Cunningham | Interim Chief Financial Officer | $275,600 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Manuel C. Alves Aivado | M.D., Ph.D. Former President and Chief Financial Officer | $630,735 |
| D. Allen Annis | Former Senior Vice President, Research | $546,148 |
| Brian Windsor | President and Chief Executive Officer | $289,642 |
| Charles T. Garner | Former principal financial officer and principal accounting officer | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Manuel C. Alves Aivado | M.D., Ph.D. Former Chief Executive Officer | $1,244,420 |
| D. Allen Annis | Former Senior Vice President, Research | $572,264 |
| Vojislav Vukovic | M.D., Ph.D. Former Senior Vice President, Chief Medical Officer | $545,703 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Manuel C. Alves Aivado | M.D., Ph.D. Chief Executive Officer | $3,280,379 |
| Richard J. Wanstall | Chief Financial Officer and Treasurer | $1,197,030 |
| Vojislav Vukovic | M.D., Ph.D. Former Senior Vice President, Chief Medical Officer | $962,386 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Manuel C. Alves Aivado | M.D., Ph.D. President and Chief Executive Officer | $1,238,458 |
| Vojislav Vukovic | M.D., Ph.D. Senior Vice President, Chief Medical Officer | $778,930 |
| Richard J. Wanstall | Chief Financial Officer and Treasurer | $715,098 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Manuel C. Alves Aivado | M.D., Ph.D. President and Chief Executive Officer | $1,178,065 |
| Vojislav Vukovic | M.D., Ph.D. Senior Vice President, Chief Medical Officer | $650,843 |
| Donald V. Dougherty | Former Senior Vice President, Chief Financial Officer | $569,738 |
| D. Allen Annis | Senior Vice President, Research | $510,482 |
| Richard J. Wanstall | Chief Financial Officer and Treasurer | $401,442 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Manuel C. Alves Aivado | M.D., President and Chief Executive Officer | $1,463,705 |
| Donald V. Dougherty | Former Senior Vice President, Chief Financial Officer | $463,280 |
| Vojislav Vukovic | M.D., Ph.D. Senior Vice President, Chief Medical Officer | $436,965 |
| D. Allen Annis | Senior Vice President, Research | $386,906 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Manuel C. Alves Aivado, M.D., Ph.D. | member of the Board of Directors | Resigned | 2026-02-19 |
| Timothy M. Cunningham | principal financial officer and principal accounting officer | Appointed | 2024-05-16 |
| Timothy M. Cunningham | interim chief financial officer | Appointed | 2024-05-16 |
| Charles Garner | principal financial officer and principal accounting officer | Appointed | 2024-03-29 |
| Susan L. Drexler | Interim Chief Financial Officer, principal financial officer and principal accounting officer | Resigned | 2024-03-29 |
| Brian Windsor, Ph.D. | Chief Executive Officer | Appointed | 2024-03-15 |
| Brian Windsor, Ph.D. | member of the Board | Appointed | 2024-03-15 |
| Manuel C. Alves-Aivado, M.D., Ph.D. | Chief Executive Officer | Resigned | 2024-03-15 |
| Nolan Sigal, M.D., Ph.D. | member of the Board of Directors | Resigned | 2024-03-01 |
| Reinhard Ambros, Ph.D. | Class III director | Appointed | 2024-02-29 |
| Josef H. von Rickenbach | Class III director | Appointed | 2024-02-29 |
| Manuel C. Alves-Aivado, M.D., Ph.D. | Class III director | Appointed | 2024-02-29 |
| William C. Fairey | Director | Appointed | 2023-10-31 |
| Alan A. Musso | Director | Appointed | 2023-10-31 |
| Brian Windsor | President and Chief Operating Officer | Appointed | 2023-10-31 |
| William C. Fairey | Director | Appointed | 2023-10-31 |
| Alan A. Musso | Director | Appointed | 2023-10-31 |
| William T. McKee | Director | Resigned | 2023-10-31 |
| Jodie P. Morrison | Director | Resigned | 2023-10-31 |
| Jeffrey A. Bailey | Chairman of the Board | Resigned | 2023-10-31 |
| Brian Windsor | President and Chief Operating Officer | Appointed | 2023-10-31 |
| Vojislav Vukovic, M.D., Ph.D. | Senior Vice President, Chief Medical Officer | Terminated | 2022-07-08 |